Perceptive Advisors’s ChemoCentryx, Inc. CCXI Stock Holding History

Perceptive Advisors’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-192,680	Closed	-$9.95M	–	125
2022 Q3	$9.95M	Sell	192,680 -249,000	-56%	-$10.3M	0.29%	66
2022 Q2	$10.9M	Sell	441,680 -1,213,399	-73%	-$26.7M	0.34%	57
2022 Q1	$41.5M	Buy	1,655,079 +239,633	+17%	+$6.73M	0.83%	31
2021 Q4	$51.5M	Buy	1,415,446 +865,446	+157%	+$30.4M	0.79%	32
2021 Q3	$9.4M	Buy	+550,000	New	+$8.57M	0.14%	106
2020 Q3	–	Sell	-10,252	Closed	-$590K	–	149
2020 Q2	$590K	Hold	10,252	–	–	0.01%	120
2020 Q1	$406K	Buy	+10,252	New	+$435K	0.01%	104

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Perceptive Advisors's CCXI Position: Q4 2022 in Review

Perceptive Advisors sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 192,680 shares — an estimated $9.95M sold.

Perceptive Advisors first reported a position in CCXI in Q1 2020 and held it in 7 quarters. The position peaked at $51.5M in Q4 2021. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Perceptive Advisors reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Perceptive Advisors sold 192,680 ChemoCentryx, Inc. shares in Q4 2022, an estimated $9.95M.
Perceptive Advisors first reported a position in ChemoCentryx, Inc. in Q1 2020 and held it in 7 quarters.
Perceptive Advisors's ChemoCentryx, Inc. position peaked at $51.5M in Q4 2021.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Perceptive Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.